Manufacturer: Geneza Pharmaceuticals
Pack: 20 tabs (25 mg/tab)
Molecular Formula: C20H32O2
Average Dose: Men 25-100 mg/day…..Women 25-50 mg/day
Water Retention: No
High Blood Pressure: Rare
Liver Toxic: Low
Active Life: up to 12 hours
Detection Time: 5-6weeks
Androgenic: Anabolic Ratio: 30-40/100-150
GP Proviron by Geneza Pharmaceuticals is an oral steroid that contain 25mg of the hormone Mesterolone per tablet.
Proviron, as it is also called, is an orally active Dihydrotestosterone preparation, that become popular among bodybuilders for different reasons. Proviron is unique in that a simple look at its 4-ring structure shows that it is not toxic for liver.
Taking Proviron with testosterone or any aromatizable steroid, will contribute to prevent estrogen build up by the aforementioned binding to the aromatase enzyme, which prevents aromatase from doing it´s bad work and making a lot of estrogen out of the other steroids you are taking. That means that this drug is estrogen blocker.
Taking into consideration that this steroid is not very anabolic, it is very androgenic. This thing makes muscles harder and more defined. Also its high androgenic properties serve for maintaining or retaining ones sex drive.
One more fact that makes GP Proviron good to use is that it reduce SHBG in the body considerably. This frees up other hormones being used and makes them much more effective.
Very often athletes incorporate this drug into all cycles, and also into their PCT programs. Combining it with testosterone, will aid in blocking estrogen while increasing androgen, and also allow the testosterone to be more abundant in the body. With this wide range of benefits associated with its addition to the cycle, it’s no wonder that this drug has gained so much popularity.
Bodybuilders often take GP Proviron in the dose of 25-200mgs per day.
You can BUY this product at discount prices from IronDaddy.ws because they proved good themselves on market and have good reputation
Written by: Golden Muscles
© May 2010 www.goldenmuscles.com All rights reserved. Reprint article with link only